On the Road to Leucine-Rich Repeat Kinase 2 Signalling: Evidence from Cellular and in vivo Studies
Author:
Publisher
S. Karger AG
Subject
Cellular and Molecular Neuroscience,Developmental Neuroscience,Neurology
Reference76 articles.
1. Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway
2. Kinase activity of mutant LRRK2 mediates neuronal toxicity
3. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
4. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
5. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date;Expert Opinion on Therapeutic Patents;2024-07-19
2. Development of a highly potent and selective degrader of LRRK2;Bioorganic & Medicinal Chemistry Letters;2023-10
3. Perspective on the current state of the LRRK2 field;npj Parkinson's Disease;2023-07-01
4. Pathogenic LRRK2 requires secondary factors to induce cellular toxicity;Bioscience Reports;2020-10
5. Comparative Genomic Mapping Implicates LRRK2 for Intellectual Disability and Autism at 12q12, and HDHD1, as Well as PNPLA4, for X-Linked Intellectual Disability at Xp22.31;Journal of Clinical Medicine;2020-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3